Sofosbuvir Completed Phase 4 Trials for Lung Diseases, Interstitial / Chronic Hepatitis C Virus (HCV) Infection / Chronic Obstructive Pulmonary Disease (COPD) / Heart Failure Treatment

Indications	Status	Purpose	Phase
DBCOND0029037 (Lung Diseases, Interstitial) DBCOND0057091 (Chronic Hepatitis C Virus (HCV) Infection) DBCOND0031289 (Chronic Obstructive Pulmonary Disease (COPD)) DBCOND0027920 (Heart Failure)	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02858180	Hepatitis C Virus(HCV) Heart and Lung Study	Sofosbuvir (DB08934) Ledipasvir (DB09027)
NCT02804386	Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon	Sofosbuvir (DB08934)
NCT02624063	Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)	Sofosbuvir (DB08934) Daclatasvir (DB09102) Simeprevir (DB06290)
NCT02482077	Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients	Daclatasvir (DB09102) Sofosbuvir (DB08934) Ribavirin (DB00811) Ledipasvir (DB09027)
NCT02480686	Neutrino Regimen for Treatment-experienced HCV GT1 Patients	Sofosbuvir (DB08934) Ribavirin (DB00811) Peginterferon alfa-2a (DB00008)
NCT02964091	Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World	Ledipasvir (DB09027) Sofosbuvir (DB08934)
NCT02168361	The SIM-SOF Trial for Hepatitis C	Sofosbuvir (DB08934) Ribavirin (DB00811) Simeprevir (DB06290) Interferon alfa-2b (DB00105) Peginterferon alfa-2b (DB00022)